Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (161-170 of 862) with videos related to

Pageof 87
Sort By:
Psychopharmacology|April 9, 2013
Old drug ifenprodil, new hope for PTSD with a history of childhood abuseKenji Hashimoto, Tsuyoshi Sasaki, Akira Kishimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Predictive factors for endocrine responsiveness in stage IV breast cancer]Chikako Shimizu, Kenji Hashimoto, Akiko Nagatsuma
Expert Review of Neurotherapeutics|August 1, 2013
Prenatal immune activation and subsequent peripubertal stress as a new model of schizophreniaNoriko Yoshimi, Takashi Futamura, Kenji Hashimoto
Neuroscience and Biobehavioral Reviews|July 2, 2022
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depressionXingming Wang, Jianjun Yang, Kenji Hashimoto
Brain, Behavior, and Immunity|September 29, 2025
D-lactate in immune regulation and neuroinflammation: beyond microbial fermentationRumi Murayama, Hiroyuki Nakamura, Kenji Hashimoto
Molecular Psychiatry|January 8, 2022
Mechanisms of action of fluvoxamine for COVID-19: a historical reviewYaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Molecular Psychiatry|May 8, 2021
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptorYan Wei, Lijia Chang, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|September 3, 2021
Old drug fluvoxamine, new hope for COVID-19Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Brain, Behavior, and Immunity|April 26, 2020
Current status of potential therapeutic candidates for the COVID-19 crisisJiancheng Zhang, Bing Xie, Kenji Hashimoto
Scientific Reports|November 18, 2016
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activationYuko Fujita, Tamaki Ishima, Kenji Hashimoto
Pageof 87

Showing results (161-170 of 862) with videos related to

Sort By:
Pageof 87
Psychopharmacology|April 9, 2013
Old drug ifenprodil, new hope for PTSD with a history of childhood abuseKenji Hashimoto, Tsuyoshi Sasaki, Akira Kishimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Predictive factors for endocrine responsiveness in stage IV breast cancer]Chikako Shimizu, Kenji Hashimoto, Akiko Nagatsuma
Expert Review of Neurotherapeutics|August 1, 2013
Prenatal immune activation and subsequent peripubertal stress as a new model of schizophreniaNoriko Yoshimi, Takashi Futamura, Kenji Hashimoto
Neuroscience and Biobehavioral Reviews|July 2, 2022
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depressionXingming Wang, Jianjun Yang, Kenji Hashimoto
Brain, Behavior, and Immunity|September 29, 2025
D-lactate in immune regulation and neuroinflammation: beyond microbial fermentationRumi Murayama, Hiroyuki Nakamura, Kenji Hashimoto
Molecular Psychiatry|January 8, 2022
Mechanisms of action of fluvoxamine for COVID-19: a historical reviewYaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Molecular Psychiatry|May 8, 2021
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptorYan Wei, Lijia Chang, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|September 3, 2021
Old drug fluvoxamine, new hope for COVID-19Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Brain, Behavior, and Immunity|April 26, 2020
Current status of potential therapeutic candidates for the COVID-19 crisisJiancheng Zhang, Bing Xie, Kenji Hashimoto
Scientific Reports|November 18, 2016
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activationYuko Fujita, Tamaki Ishima, Kenji Hashimoto
Pageof 87